FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2026
Back to search
Official data from USPTO
NEXA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
06/30/2026
Trademark type
Word
Nice classes
5, 9, 10
Filing date
12/23/2022
Registration date
03/31/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
83
Owner location
AU
Examiner
BROWN, TINA
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Cochlear Limited
Representatives
WILLIAM M. BRYNER KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; medical preparations for the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; pharmaceutical drugspharmaceutical preparations for the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; corticosteroids; steroidsdexamethasone; anti-inflammatory drugs; chemical reagents for medical purposes; chemical preparations for medical purposesfor the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; all the foregoing for or in relation to the inner ear or auditory system of a human; none of the foregoing for use in laboratory-testing or medical-transport applicationspackaged or sold primarily in connection with vialstest tubessyringesnon-implantable cartridgesnon-implantable medical fluid containers for such applications
Class 9
Downloadable and recorded software for managing clinical data; computer softwarerecorded for data analysisdatabases managementmanaging data for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; downloadable computer programs for data analysisdatabases managementmanaging data for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; computer software applicationsdownloadable for data analysisdatabases managementmanaging data for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; all the foregoing for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; none of the foregoing in the field of digital imaging or digital image processinganalysismeasurementdisplay comparison or simulation of effects of surgical or product treatment outcomes
Class 10
Medical deviceshearing aidscochlear implants made from artificial materials and in-ear monitors for medical purposescomponents of medical devicessound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; prosthetic hearing devices and components of prosthetic hearing deviceshearing aidssound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; accessories for use with prosthetic hearing deviceswireless transmitters and receivers for use with hearing aids; medical implantsan implanted hearing device in the nature of a cochlear implant made from artificial materialsfor delivering pharmaceutical preparationsmedical preparationspharmaceutical drugscorticosteroidsdexamethasoneanti-inflammatory drugschemical reagentschemical preparations to the inner ear or auditory system of a human; none of the foregoing for laboratory-testing or medical-transport usesnone of the foregoing non-implantable fluid-delivery containerscartridgessyringesvialstest tubes sold for such uses
Publications
History of USPTO decisions and trademark events.
51 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2026
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/10/2026
OP.T
OPPOSITION TERMINATED NO. 999999
03/10/2026
OP.D
OPPOSITION DISMISSED NO. 999999
03/10/2026
RFNT
REFUSAL PROCESSED BY IB
01/17/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
12/17/2024
OP.I
OPPOSITION INSTITUTED NO. 999999
12/16/2024
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
12/16/2024
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
12/15/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/27/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/27/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/27/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/27/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/27/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/27/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/25/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/25/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/01/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/25/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2024
PUBO
PUBLISHED FOR OPPOSITION
06/18/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/11/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/14/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/14/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/14/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/14/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/02/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/20/2024
GNFR
FINAL REFUSAL E-MAILED
04/20/2024
CNFR
FINAL REFUSAL WRITTEN
04/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2024
RFNT
REFUSAL PROCESSED BY IB
11/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/06/2023
RFRR
REFUSAL PROCESSED BY MPU
10/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/27/2023
CNRT
NON-FINAL ACTION WRITTEN
09/26/2023
DOCK
ASSIGNED TO EXAMINER
09/24/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/27/2023
Continuous trademark protection
Get notified about every new filing that threatens NEXA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.